Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for perioperative bleeding in adenotonsillectomy
IRCT20180404039191N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of tranexamic acid in Tonsillar hyperplasia, chronic tonsillitis, recurrent tonsillitis and 2 more (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Perioperative bleeding volume. Started Sep 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Tonsillar hyperplasiachronic tonsillitisrecurrent tonsillitisobstructive sleep apnea hypopnea syndrome (OSAHS)adenoiditis
Beyond the preview
Go deeper on IRCT20180404039191N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180404039191N1.